Optimize Your CCTA + Heartflow Program for Reimbursement Success in 2027

Description

Many cardiovascular programs don’t yet realize that AI-enabled coronary plaque analysis (AI-CPA) now has a Category I CPT code, significant and expanding commercial payer coverage and established payment. This could lead to missed reimbursements for services they’re already providing. Join Heartflow’s market access experts to learn what the Centers for Medicare & Medicaid Services (CMS) 2027 Final Rules and payer landscape mean for cardiac computed tomography angiography (CCTA), fractional flow reserve-computed tomography (FFRct) and AI-CPA. Attendees with learn actionable steps to secure coverage, code correctly, and get paid appropriately across the full coronary artery disease (CAD) diagnostic pathway.

After this webinar, participants will be able to:
1. Interpret the CMS 2027 Final Rules for CCTA (75574), FFRct (75580), and AI-CPA (75577), including 2027 national payment rates under the Physician Fee Schedule (PFS) and Outpatient Prospective Payment System (OPPS).
2. Explain CMS’s 2027 Software as a Medical Service (SaMS) payment policy and what it signals for how AI-enabled cardiovascular diagnostics like FFRct and AI-CPA will be valued and paid going forward.
3. Navigate the commercial payer coverage landscape for FFRct and AI-CPA, including where coverage is expanding, where prior authorization applies, and how to keep payer policies current.
4. Apply compliant coding and billing practices across the full CAD diagnostic pathway to prevent denials, support appropriate payment, and position the program for Jan. 1, 2027.
5. Strengthen revenue integrity through chargemaster, revenue code, and cost-reporting practices that produce accurate hospital claims data and inform future CMS rate-setting.

Speakers

Cara Santillo, Senior Vice President Market Access & Reimbursement, Heartflow
Christopher Pauwels, Director, Payer Relations, Heartflow
Kari McClure, Senior Field Billing Manager, Heartflow